Literature DB >> 26453112

Genetic of uveitis.

Francesco Pichi1,2, Paola Carrai3, Sunil K Srivastava4, Careen Y Lowder4, Paolo Nucci3, Piergiorgio Neri5.   

Abstract

Immune-mediated uveitis may be associated with a systemic disease or may be localized to the eye. T-cell-dependent immunological events are increasingly being regarded as extremely important in the pathogenesis of uveitis. Several studies have also shown that macrophages are major effectors of tissue damage in uveitis. Uveitis phenotypes can differ substantially, and most uveitis diseases are considered polygenic with complex inheritance patterns. This review attempts to present the current state of knowledge from in vitro and in vivo research on the role of genetics in the development and clinical course of uveitis. A review of the literature in the PubMed, MEDLINE, and Cochrane databases was conducted to identify clinical trials, comparative studies, case series, and case reports describing host genetic factors as well as immune imbalance which contribute to the development of uveitis. The search was limited to primary reports published in English with human subjects from 1990 to the present, yielding 3590 manuscripts. In addition, referenced articles from the initial searches were hand searched to identify additional relevant reports. After title and abstract selection, duplicate elimination, and manual search, 55 papers were selected for analysis and reviewed by the authors for inclusion in this review. Studies have demonstrated associations between various genetic factors and the development and clinical course of intraocular inflammatory conditions. Genes involved included genes expressing interleukins, chemokines, chemokine receptors, and tumor necrosis factor and genes involved in complement system. When considering the genetics of uveitis, common threads can be identified. Genome-wide scans and other genetic methods are becoming increasingly successful in identifying genetic loci and candidate genes in many inflammatory disorders that have a uveitic component. It will be important to test these findings as uveitis-specific genetic factors. Therefore, the burgeoning understanding of the human genome promises to result in new insight into the pathogenesis of uveitis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26453112     DOI: 10.1007/s10792-015-0136-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  55 in total

Review 1.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

2.  Acute anterior uveitis and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

3.  HLA antigens in uveitis.

Authors:  D Wakefield; J Wright; R Penny
Journal:  Hum Immunol       Date:  1983-06       Impact factor: 2.850

4.  Close association of HLA-Bw51 with Behçet's disease.

Authors:  S Ohno; M Ohguchi; S Hirose; H Matsuda; A Wakisaka; M Aizawa
Journal:  Arch Ophthalmol       Date:  1982-09

5.  HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease.

Authors:  N Mizuki; M Ota; Y Katsuyama; K Yabuki; H Ando; T Shiina; E Nomura; K Onari; S Ohno; H Inoko
Journal:  Tissue Antigens       Date:  2001-09

Review 6.  Overview of safety of non-biologic and biologic DMARDs.

Authors:  Eric M Ruderman
Journal:  Rheumatology (Oxford)       Date:  2012-12       Impact factor: 7.580

Review 7.  Complement factor H related proteins in immune diseases.

Authors:  Christine Skerka; Peter F Zipfel
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

8.  Chemokine gene expression in iris-ciliary body during experimental autoimmune uveoretinitis.

Authors:  Kouichi Ohta; Satoru Yamagami; Barbara Wiggert; M Reza Dana; J Wayne Streilein
Journal:  Curr Eye Res       Date:  2002-06       Impact factor: 2.424

Review 9.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

10.  CFH 184G as a genetic risk marker for anterior uveitis in Chinese females.

Authors:  Ming-ming Yang; Timothy Y Y Lai; Pancy O S Tam; Sylvia W Y Chiang; Carmen K M Chan; Fiona O J Luk; Tsz Kin Ng; Chi-Pui Pang
Journal:  Mol Vis       Date:  2011-10-13       Impact factor: 2.367

View more
  5 in total

1.  Whole-Exome Sequencing of Patients With Posterior Segment Uveitis.

Authors:  Angela S Li; Gabriel Velez; Benjamin Darbro; Marcus A Toral; Jing Yang; Stephen H Tsang; Polly J Ferguson; James C Folk; Alexander G Bassuk; Vinit B Mahajan
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258

2.  Uveitis and Multiple Sclerosis: Potential Common Causal Mutations.

Authors:  Alejandra de-la-Torre; Claudia T Silva-Aldana; Juliana Muñoz-Ortiz; Laura B Piñeros-Hernández; Oscar Otero; Alejandra Domínguez; León A Faciolince; Mauricio Arcos-Holzinger; Claudio Mastronardi; Nora Constanza Contreras-Bravo; Carlos Martín Restrepo; Mauricio Arcos-Burgos
Journal:  Mol Neurobiol       Date:  2019-06-03       Impact factor: 5.590

Review 3.  Optical coherence tomography angiography in uveitis.

Authors:  Paris Tranos; Evdoxia-Maria Karasavvidou; Olga Gkorou; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-12-23

Review 4.  Immunological tests and their interpretation in uveitis.

Authors:  S R Rathinam; Ilknur Tugal-Tutkun; Mamta Agarwal; Vedhanayaki Rajesh; Merih Egriparmak; Gazal Patnaik
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 5.  Pearls and pitfalls of optical coherence tomography angiography in the multimodal evaluation of uveitis.

Authors:  Francesco Pichi; David Sarraf; Mariachiara Morara; Shahana Mazumdar; Piergiorgio Neri; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2017-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.